BEVAZZA 400MG/16ML INJECTION

Bevarest 100mg Injection is a recombinant monoclonal antibody that belongs to the immunotherapy class of cancer treatment. It can either be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.

While for women with reproductive potential subjected to BEVAZZA 400MG/16ML INJECTION, it is advised to discuss with your doctor regarding the effective birth control methods during the treatment. Also to be continued for a minimum of 6 months after the treatment course completion as this medicine may impair fertility.

BEVAZZA 400MG/16ML INJECTION is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28days before or after surgery.

All the side effects that are relatively caused by BEVAZZA 400MG/16ML INJECTION occur until the drug concentration stays in the body. It is found that this medicine will be contained in our body for almost 4 months after the final dose.

BEVAZZA 400MG/16ML INJECTION is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age. The first dose will be administered for 90 minutes and if well tolerated the infusion time can be reduced to 30 minutes.

Inform your physician before starting your treatment with BEVAZZA 400MG/16ML INJECTION in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.

There is NULL interaction of BEVAZZA 400MG/16ML INJECTION with other drugs

It is vital to inform your physician before taking BEVAZZA 400MG/16ML INJECTION if you have the following conditions: * Have conditions involving inflammation in the stomach (ulcer, colitis). * Experience allergic reactions to BEVAZZA 400MG/16ML INJECTION or its ingredients. * Have recently undergone surgery as it is associated with the risk of bleeding. * Have diabetes, hypertension, or heart problems.

Bevacizumab is a molecule/combination used for making BEVAZZA 400MG/16ML INJECTION. It is a monoclonal antibody that works by targeting and blocking the growth of blood vessels in cancer cells.

BEVAZZA 400MG/16ML INJECTION is an anti-angiogenic medicine used in Oncology to treat certain types of cancer. It works by blocking blood vessels from reaching cancer cells, thus preventing tumor growth and spread.

BEVAZZA 400MG/16ML INJECTION, when used in Oncology, helps in treating cancer by cutting off the blood supply to cancer cells. This medicine inhibits the growth of blood vessels that feed tumors, helping to slow down tumor growth and spread.